Eptinezumab in treatment-resistant chronic migraine: Four-year real-world effectiveness and treatment persistence. Hsieh WJ, Nicol K, Ng CC, Hou TW, et al. Cephalalgia 2026;46:3331024261451427.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hsieh WJ, Nicol K, Ng CC, Hou TW, et al. Eptinezumab in treatment-resistant chronic migraine: Four-year real-world effectiveness and treatment persistence. Cephalalgia 2026;46:3331024261451427.
PMID: 42153799